NGNE stock news
This page provides real-time market news, earnings updates, and company announcements related to Neurogene Inc. (NGNE).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-05 10:03 EST
Neurogene Inc (ticker: NGNE) shares surged 32% in pre-market trading after the company announced that its experimental therapy for rare neurological diseases has received "Breakthrough Therapy" designation from the U.S. Food and Drug Administration (FDA).
老虎证券2026-02-27 11:24:37
Neurogene Stock Soars On FDA Breakthrough Tag For Rett Gene Therapy
Finviz2026-02-27 13:09:09
Block receives an upgrade, Duolingo faces a downgrade: Leading analyst picks from Wall Street
101 finance2026-02-27 15:01:03
NGNE stock chart
NGNE stock detailsNGNE stock price change
On the last trading day, NGNE stock closed at 24.07 USD, with a price change of 9.44% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more